4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0000897069-25-001793
10% owner sold 6,612 shares at an average $8.25 ($54,575)
- 10% owner acquired 395 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Peyer James 10% owner | 2025-12-08 | Sale | −3,105 | $8.59 | $26,672 | 158,254 | I |
| Peyer James 10% owner | 2025-12-09 | Sale | −2,666 | $7.95 | $21,195 | 155,588 | I |
| Peyer James 10% owner | 2025-12-09 | Option exercise | +395 | $6.40 | $2,528 | 155,983 | I |
| Peyer James 10% owner | 2025-12-09 | Sale | −395 | $8.04 | $3,176 | 155,588 | I |
| Peyer James 10% owner | 2025-12-09 | Sale | −446 | $7.92 | $3,532 | 155,142 | I |
| Derivatives | |||||||
| Peyer James 10% owner | 2025-12-09 | Option exercise · Stock Option (Right to Buy) | −395 | 0 | D | ||
| Open-market sales · 6,612 sh · avg $8.25 · $54,575 | |||||||
Loading xslF345X05/form4.xml…